Home » Uncategorized

Ampio Shares Booming on Positive Test Results (AMPE)

7 views No Comment
Drug maker Ampio Pharmaceuticals Inc. (NASDAQ: AMPE) reported this morning that clinical trials of the company’s Optina treatment for a type of macular disease have been successful: A preliminary...


Comments are closed.